A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy.
Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, Black DM, Santiago L, Hobbs BP, Lucci A Jr, Gilcrease M, Hwang RF, Candelaria RP, Chavez-MacGregor M, Smith BD, Arribas E, Moseley T, Teshome M, Miggins MV, Valero V, Hunt KK, Yang WT.
Kuerer HM, et al. Among authors: arribas e.
Ann Surg. 2018 May;267(5):946-951. doi: 10.1097/SLA.0000000000002313.
Ann Surg. 2018.
PMID: 28549010
Free PMC article.
Clinical Trial.